Portfolio company
Mediar Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
Deep Tech
About
The company develops antibody treatments for patients with fibrotic diseases such as idiopathic pulmonary fibrosis and systemic sclerosis to halt or reverse organ scarring.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.